A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. (Q46704118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

David Burn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ian G. McKeith

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Alan J Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Elise N Rowan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Elizabeth Littlewood

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jane Newby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sanjeet Pakrasi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jonathan Richardson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jonathan Sanders

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Geriatric Psychiatry

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

938-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

6 January 2020

cites work

1 reference

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

21 January 2018

1 reference

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

21 January 2018

1 reference

7 January 2021

Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies

1 reference

7 January 2021

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

1 reference

7 January 2021

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

7 January 2021

Impact of Behavioral and Psychological Symptoms of Dementia on Caregivers

1 reference

7 January 2021

Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease

1 reference

7 January 2021

Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

1 reference

7 January 2021

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

1 reference

7 January 2021

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study

1 reference

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

7 January 2021

Dementia associated with Parkinson's disease

1 reference

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

7 January 2021

Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

1 reference

7 January 2021

1 reference

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

7 January 2021

Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial

1 reference

7 January 2021

Donepezil for behavioural disorders associated with Lewy bodies: a case series

1 reference

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

7 January 2021

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

1 reference

7 January 2021

Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies

1 reference

7 January 2021

What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.

1 reference

7 January 2021

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

1 reference

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

7 January 2021

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

1 reference

7 January 2021

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

1 reference

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

7 January 2021

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

7 January 2021

The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale

1 reference

7 January 2021

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.1381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16163744%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference